Sigma-Aldrich to Buy U.S. Biopharma Services Firm for $350 Million

Sigma-Aldrich has agreed to acquire BioReliance Holdings (Rockville, MD), a provider of global biopharmaceutical testing services, for $350 million in cash from Avista Capital Partners (New York). Subject to regulatory clearance, the deal is expected to close in the first quarter of this year.    BioReliance generated sales in 2010 of approximately $110 million, with double-digit growth expected for 2011. In addition to its activities in Rockville, BioReliance has operations in Glasgow and Stirling, U.K. and sales offices in Tokyo and Bangalore. It...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers